Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Abstract

Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.

U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
Drug Metabolism and Disposition September 1994, 22 (5) 667-672;
U Köster
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Speerschneider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Kerssebaum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Wittmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W Dekant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

1,1,2,3,3,3-Hexafluoropropyl methyl ether is developed as an alternative to replace ozone-depleting chlorofluorocarbons. The metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether was studied in rat and human liver microsomes and in rats in vivo. Rat and human liver microsomes metabolized 1,1,2,3,3,3-hexafluoropropyl methyl ether to inorganic fluoride and formaldehyde in a ratio of 2:1. 2,3,3,3-Tetrafluoropropionic acid was also identified as a metabolite by GC/MS and 19F-NMR. In rat liver microsomes, formation of inorganic fluoride and formaldehyde from 1,1,2,3,3,3-hexafluoropropyl methyl ether was dependent on the presence of NADPH, time, substrate concentration and protein concentration, and was linear for up to 35 min. Microsomes from unpretreated rats oxidized 1,1,2,3,3,3-hexafluoropropyl methyl ether at low rates (3.56 nmol fluoride.20 min-1.mg-1). Pretreatment of rats with pyridine and ethanol, inducers of cytochrome P450 2E1, increased the rate of fluoride formation. The rates of fluoride formation from 1,1,2,3,3,3-hexafluoropropyl methyl ether correlated well with the relative amount of cytochrome P450 2E1 in the microsomes as quantified by immunoblotting. Coincubation of 1,1,2,3,3,3-hexafluoropropyl methyl ether with microsomes and diethyldithiocarbamate (100 microM), an inhibitor of cytochrome P450 2E1, reduced fluoride production by > 80%. In different samples of human liver microsomes, rates of fluoride formation were higher than observed in liver microsomes from unpretreated rats and correlated well to the content of cytochrome P450 2E1 protein as determined by immunoblotting and chlorzoxazone 6-hydroxylation.(ABSTRACT TRUNCATED AT 250 WORDS)

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 22, Issue 5
1 Sep 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract

Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.

U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
Drug Metabolism and Disposition September 1, 1994, 22 (5) 667-672;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Abstract

Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.

U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
Drug Metabolism and Disposition September 1, 1994, 22 (5) 667-672;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics